Scalable Production & Characterization of Non- Immunogenic ARMMs Particles

Time: 12:00 pm
day: Day 2 Track B – AM


  • Using scalable, GMP-compliant processes, we can produce ARMMs efficiently payloaded with biomolecules of interest such as gene editors.
  • ARMMs in vivo: how the route of administration affects biodistribution and the specific cell types which take up ARMMs
  • Repeated administration in immunocompetent mice is safe, supporting their use as a non-viral delivery method